In partnership with @SysmexEurope, we’d like to support the @NHSUK by donating free @MagtraceSurgery lymphatic tracer vials to UK hospitals.
We hope this will help hospitals continue to carry out essential breast cancer treatment during these unprecedented times.
(1/7)
The extended use of the #Magseed® magnetic marker is now approved for long-term use in any soft tissue across Europe! https://t.co/C3mOAclOGz #Endomag#Sysmex
Why is it advantageous to mark clinically positive lymph nodes before starting neoadjuvant systemic therapy (NAST)? Let us know: https://t.co/u2ODsXUQlv
Antibiotic resistance is one of the most urgent global health threats. Everyone has a role to play in improving antibiotic use to help fight #AntibioticResistance.
Looking to move on from guide-wires for lumpectomies and radioisotope use in axillary management?
See why many of the world’s leading hospitals use our products to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is.
Another first in #breastcancer - Virtual Peer-to-Peer Training
Andrea Behr, MD from @SSMHealthSTL watching #Magtrace/#Magseed surgery performed by @mdAlvaradoMD at @UCSF
“This is so awesome! To be able to see how Michael operates is so helpful” Dr Behr
We are ready! Looking forward to see you all today at our Sysmex lunch symposium at #EUSOBI2019 in Budapest. On the programme we have for you inspiring talks about #Magseed non-radioactive lesion and lymph node localisation. #radiology#breastcancer#breastimaging
Dr Rajiv Dave Oncoplastic Surgeon from Manchester University NHS Foundation showing Dr Maisam Fazel Oncoplastic Surgeon Sentimag. Dr Dave will be performing and teaching Magseed retrieval at Aga Khan University Hospital. First ever in Kenya
Honoured to have performed and taught the first Magseed-guided excision in 🇰🇪. Thanks @Julie93213176 of @SysmexUK South Africa and @m_mutebi of @AKUGlobal Hospital for facilitating this. It’s been a pleasure to share knowledge and skills at this symposium with @ABSGBI colleagues.
Have you seen the SentimagIC non-inferiority trial results?
The paper demonstrates that @MagtraceSurgery is a viable non-radioactive alternative to Technetium-99m and Blue Dye for axillary SLN detection in early-stage breast cancer.
➡️ PubMed link here: https://t.co/WmRo4VdeXs
First sentimag sentinel lymph node biopsy at Frere Provincial Hospital Eastern Cape. Patients usually have axillary dissection. Great news for our patients. Dr Bhattarai thank you
Why adopt #Magtrace as your new non-radioactive tracer for SLNB?
Here's an article from @UHhospitals and @DrJDietz who explain how our technologies have enabled better, more personalized care for women with breast cancer.
📰 https://t.co/U4H6zOcgBq
#breastcancer#bcsm#bccww